PD
FLGT icon

Point72 (DIFC)’s Fulgent Genetics FLGT Stock Holding History

Point72 (DIFC)’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.28K Buy
278
+231
+491% +$4.76K ﹤0.01% 989
2025
Q2 		$934 Sell
47
-7,339
-99% -$143K ﹤0.01% 1438
2025
Q1 		$125K Buy
7,386
+270
+4% +$4.6K 0.01% 1023
2024
Q4 		$131K Buy
7,116
+5,002
+237% +$97.7K ﹤0.01% 952
2024
Q3 		$45.9K Buy
+2,114
New +$47.3K ﹤0.01% 1102
2024
Q2 		– Sell
-73
Closed -$1.58K – 1603
2024
Q1 		$1.58K Buy
+73
New +$1.81K ﹤0.01% 1401

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Point72 (DIFC)'s FLGT Position: Q3 2025 in Review

Point72 (DIFC) increased its Fulgent Genetics (FLGT) stake by 491% in Q3 2025, buying an estimated $4.76K and bringing the position to 278 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Point72 (DIFC) first reported a position in FLGT in Q1 2024 and has held it in 6 quarters since. The position peaked at $131K in Q4 2024. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Point72 (DIFC) held 278 shares of Fulgent Genetics worth $6.28K as of Q3 2025.
  • Point72 (DIFC) bought 231 Fulgent Genetics shares in Q3 2025, an estimated $4.76K.
  • Fulgent Genetics made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #989 holding.
  • Point72 (DIFC) first reported a position in Fulgent Genetics in Q1 2024 and has held it in 6 quarters since.
  • Point72 (DIFC)'s Fulgent Genetics position peaked at $131K in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.